{"protocolSection":{"identificationModule":{"nctId":"NCT06480123","orgStudyIdInfo":{"id":"ZZ-SC-EXOME-DF 026"},"organization":{"fullName":"Second Affiliated Hospital of Guangzhou Medical University","class":"OTHER"},"briefTitle":"Stem Cell Derived Exome for Treatment of Diabetic Foot","officialTitle":"Skin Drug Prepared From Stem Cell Derived Exome for Treatment of Diabetic Foot: a Phase II Clinical Trial"},"statusModule":{"statusVerifiedDate":"2024-06","overallStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-08-01","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2028-12-30","type":"ESTIMATED"},"completionDateStruct":{"date":"2033-12-30","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-06-23","studyFirstSubmitQcDate":"2024-06-26","studyFirstPostDateStruct":{"date":"2024-06-28","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-06-26","lastUpdatePostDateStruct":{"date":"2024-06-28","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Second Affiliated Hospital of Guangzhou Medical University","class":"OTHER"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This trial is designed to investigate the safety and efficacy of patients with diabetic foot by using stem cell derived exome.","detailedDescription":"It is estimated that about 150 million people are suffering diabetes mellitus, of whom more than 15% will develop foot ulcers or gangrene at some times, so called diabetic foot. The diabetic foot is very difficult to cure by traditional approaches.\n\nThis phase I clinical trial is designed to assess the safety and theraputical benefit of the stem cell derived exome."},"conditionsModule":{"conditions":["Diabetic Foot","Stem Cell"],"keywords":["Diabetic foot","Stem cell","Exome","Skin drug"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE1","PHASE2"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":50,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Stem Cell Derived Exome","type":"EXPERIMENTAL","interventionNames":["Drug: Skin drug prepared with exome originated from stem cell"]}],"interventions":[{"type":"DRUG","name":"Skin drug prepared with exome originated from stem cell","description":"Skin drug prepared with exome originated from stem cell will be applied to patient with diabetic foot.","armGroupLabels":["Stem Cell Derived Exome"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Safety of the treatment","description":"Safety will be assessed by recording all types of advise effects upon and after the treatment.","timeFrame":"Six months"},{"measure":"Efficacy of the treatment","description":"Efficacy will be defined as objective response rate + steady disease rate.","timeFrame":"Six months"}],"secondaryOutcomes":[{"measure":"Duration of remission (DOR)","description":"DOR will be defined as the duration of the diabetic foot remission.","timeFrame":"5 years"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Clinical diagnosis of diabetic foot.\n2. Signed informed consent before recruiting.\n3. Age above 18 years or less than 90 years.\n4. ECOG score \\< 4\n5. Tolerable coagulation function or reversible coagulation disorders\n6. Laboratory examination test within 7 days prior to procedure: WBC≥3.0×10E9/L; Hb≥90g/L； PLT ≥50×10E9/L；INR \\< 2.3 or PT \\< 6 seconds above control；Cr ≤ 145.5 umul/L；Albumin \\> 28 g/L；Total bilirubin \\< 51 μmol/L\n7. Willing and able to comply with scheduled visits, treatment plan and laboratory tests.\n\nExclusion Criteria:\n\n1. Patients participated in clinical trials of equipment or drugs (signed informed consent) within 4 weeks;\n2. Patients accompany by ascites, hepatic encephalopathy and esophageal and gastric varices bleeding;\n3. Any serious accompanying disease, which is expected to have an unknown, impact on the prognosis, include heart disease, inadequately controlled diabetes and psychiatric disorders;\n4. Patients have poor compliance.\n5. Allergic to the skin drug;\n6. Any agents which could affect the absorption or pharmacokinetics of the study drugs\n7. Other conditions that investigator decides not suitable for the trial.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"90 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Zhenfeng Zhang, MD, PhD","role":"CONTACT","phone":"+862039195966","email":"zhangzhf@gzhmu.edu.cn"},{"name":"Bingjia He, MD","role":"CONTACT","phone":"+862039195965","email":"464677938@qq.com"}],"overallOfficials":[{"name":"Zhenfeng Zhang, MD, PhD","affiliation":"Second Affiliated Hospital of Guangzhou Medical University","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"The Second Affiliated Hospital of Guangzhou Medical University","city":"Guangzhou","state":"Guangdong","zip":"510260","country":"China","geoPoint":{"lat":23.11667,"lon":113.25}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-07-01"},"conditionBrowseModule":{"meshes":[{"id":"D000017719","term":"Diabetic Foot"}],"ancestors":[{"id":"D000003925","term":"Diabetic Angiopathies"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000016523","term":"Foot Ulcer"},{"id":"D000007871","term":"Leg Ulcer"},{"id":"D000012883","term":"Skin Ulcer"},{"id":"D000012871","term":"Skin Diseases"},{"id":"D000048909","term":"Diabetes Complications"},{"id":"D000003920","term":"Diabetes Mellitus"},{"id":"D000004700","term":"Endocrine System Diseases"},{"id":"D000003929","term":"Diabetic Neuropathies"}],"browseLeaves":[{"id":"M19933","name":"Diabetic Foot","asFound":"Diabetic Foot","relevance":"HIGH"},{"id":"M7120","name":"Diabetic Angiopathies","relevance":"LOW"},{"id":"M17400","name":"Vascular Diseases","relevance":"LOW"},{"id":"M17206","name":"Ulcer","relevance":"LOW"},{"id":"M18919","name":"Foot Ulcer","relevance":"LOW"},{"id":"M10883","name":"Leg Ulcer","relevance":"LOW"},{"id":"M15686","name":"Skin Ulcer","relevance":"LOW"},{"id":"M15674","name":"Skin Diseases","relevance":"LOW"},{"id":"M7115","name":"Diabetes Mellitus","relevance":"LOW"},{"id":"M26004","name":"Diabetes Complications","relevance":"LOW"},{"id":"M7862","name":"Endocrine System Diseases","relevance":"LOW"},{"id":"M7124","name":"Diabetic Neuropathies","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"BC17","name":"Skin and Connective Tissue Diseases"},{"abbrev":"BC19","name":"Gland and Hormone Related Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC18","name":"Nutritional and Metabolic Diseases"},{"abbrev":"BC10","name":"Nervous System Diseases"}]}},"hasResults":false}